The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Biogen IDEC

  • BIIB
  • NASDAQ
  • Consumer Products
  • Latest 290.54
  • Currency US$
  • Change -0.94
  • Percent Change -0.322 %
  • Volume 1,283,744
  • Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
Average recommendation
19 Analysts Reporting (Apr 17, 2014)
Strong Buy
Buy
Hold
Underperform
Sell
Change over time
Analyst rating breakdown
  Latest 4 weeks ago 2 months ago 3 months ago Last Year
Strong Buy 13 14 14 14 9
Buy 0 0 0 0 1
Hold 6 6 6 6 11
Underperform 0 0 0 0 0
Sell 0 0 0 0 0

As of Sun Apr 20, 2014 12:54 PM EDT
The consensus recommendation is the average buy, sell or hold rating for a company, based on a survey of brokerage equity analysts by Zacks Investment Research. We update the ratings daily.

Earnings & Estimates

Short Term
    Q1/12 Q2/12 Q3/12 Q4/12 Q1/13 Q2/13 Q3/13 Q4/13 Q1/14 Q2/14  

Actual quarterly earnings for the past eight quarters and estimated for the next two quarters

Estimated EPS ($)   1.44 1.56 1.61 1.46 1.60 1.83 2.14 2.22 2.58 2.68  
Actual EPS   1.39 1.82 1.90 1.40 1.96 2.30 2.34 2.33 -- --  
Surprise (%)   -3.5 16.7 18.0 -4.1 22.5 25.7 9.4 5.0 -- --  
Est. % Chg from Prior Year   -0.0 0.3 0.2 -0.1 0.4 0.3 0.2 0.7 31.4 16.3  
{#} Analysts   8 6 7 9 6 5 6 5 4 4  
Date of Earnings   May 01 Jul 24 Oct 25 Jan 28 Apr 25 Jul 25 Oct 28 Jan 29 Apr 23 Jul 24  

Data provided by Zacks Investment Research.

Long Term
    2014 2015  

Estimated annual earnings for the next
two years

Estimated EPS ($)   11.29 14.56  
Actual EPS   8.93 11.29  
Surprise (%)   -- --  
Est. % Chg from Prior Year   26.4 29.0  
{#} Analysts   4 4  
Date of Earnings   -- --  

Trends & Revisions

Earnings Per Share Trend
  Current 7-Days Ago 30-Days Ago 60-Days Ago 90-Days Ago
  Mean Mean Mean Mean Mean
Current Quarter (ends Mar 2014) 2.58 2.58 2.56 2.56 2.60
Next Quarter (ends Jun 2014) 2.68 2.68 2.65 2.62 2.72
Current Fiscal Year (ends Dec 2014) 11.29 11.29 11.15 11.33 11.80
Next Fiscal Year (ends Dec 2015) 14.56 14.56 14.31 14.28 14.60

Data provided by Zacks Investment Research.

Earnings Revisions
Last 7 Days Last 30 Days
Up Revs Down Revs Up Revs Down Revs
0 0 1 0
0 0 1 0
0 0 1 0
0 0 1 0